Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.22
0.01 (0.83%)
At close: Sep 26, 2025, 3:58 PM
1.18
-3.38%
After-hours: Sep 26, 2025, 04:12 PM EDT
0.83% (1D)
| Bid | 1.13 |
| Market Cap | 49.23M |
| Revenue (ttm) | 14.97M |
| Net Income (ttm) | -69.42M |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -0.71 |
| Forward PE | -0.92 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.28 |
| Volume | 37,575 |
| Avg. Volume (20D) | 1,245,592 |
| Open | 1.10 |
| Previous Close | 1.21 |
| Day's Range | 1.10 - 1.24 |
| 52-Week Range | 0.64 - 2.92 |
| Beta | -0.74 |
| Ex-Dividend Date | n/a |
About BRNS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BRNS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BRNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+10.45%
Barinthus Biotherapeutics shares are trading highe...
Unlock content with
Pro Subscription
3 months ago · accessnewswire.com
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025OXFORD, GB AND GERMANTOWN, MD / ACCESS Newswire / June 9, 2025 / Barinthus Biotherapeutics plc announced that Bill Enright, CEO, will be presenting at the Investor Summit Virtual taking place on June ...